levoleucovorin and Telangiectasia--Hereditary-Hemorrhagic

levoleucovorin has been researched along with Telangiectasia--Hereditary-Hemorrhagic* in 1 studies

Other Studies

1 other study(ies) available for levoleucovorin and Telangiectasia--Hereditary-Hemorrhagic

Article	Year
Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab. Annals of hematology, 2006, Volume: 85, Issue:9 Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Fluorouracil; Gastrointestinal Hemorrhage; Humans; Leucovorin; Male; Mesothelioma; Organoplatinum Compounds; Telangiectasia, Hereditary Hemorrhagic; Vascular Endothelial Growth Factor A	2006

Article

Year

Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab.

Annals of hematology, 2006, Volume: 85, Issue:9

Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Fluorouracil; Gastrointestinal Hemorrhage; Humans; Leucovorin; Male; Mesothelioma; Organoplatinum Compounds; Telangiectasia, Hereditary Hemorrhagic; Vascular Endothelial Growth Factor A

2006